• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


Price not available for ALGZF:US

Snapshot for Algeta ASA (ALGZF)

Open: - Day's Range: - Volume: 0
Previous Close: 60.3900 52wk Range: - 1-Yr Rtn: -

Stock Chart for ALGZF

No chart data available.
  • ALGZF:US 60.3900
  • 1M
  • 1Y
Interactive ALGZF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALGZF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 50,090.1510
Relative P/E vs. SPX -
Earnings Per Share (NOK) (ttm) -
Est. EPS (NOK) (12/2014) 0.0090
Est. PEG Ratio 2,028.7627
Market Cap (M USD) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALGZF

No data available

Company Profile & Key Executives for ALGZF

Algeta ASA operates in the pharmaceutical industry. The Company develops targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. Algeta's compound Alpharadin is designed to treat bone metastases.

Thomas RamdahlManaging DirectorOystein SougChief Financial Officer
Roger HarrisonChief Business OfficerGillies O'Bryan TearChief Medical Officer
More Company Profile & Key Executives for ALGZF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil